Concepedia

Author

Shanika de Silva

University of Exeter

Also Known As

Louise Lacey, Shanika de Silva, Sheldon C Cooper

18

Publications

2.2K

Citations

11

H-Index

9

Concepts

All Affiliations

University of ExeterGuy's and St Thomas' NHS Foundation TrustWestern General HospitalBarts Health NHS TrustUniversity of Edinburgh
SD

About

Shanika de Silva is an author at University of Exeter specializing in gastroenterology, medicine, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

835

2

Gastroenterology

2

2

835

3

Immunology

1

1

655

4

Clinical Epidemiology

1

1

655

5

Inflammation

1

1

655

Shanika de Silva

×

7

Publications

1.7K

Citations

7

H-Index

YearCitations

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green,

˜The œLancet. Gastroenterology & hepatology

2019

655

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas,

Gastroenterology

2019

385

A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

Nurulamin M Noor, James Lee, Simon Bond,

˜The œLancet. Gastroenterology & hepatology

2024

229

Postoperative Complications and Mortality Following Colectomy for Ulcerative Colitis

Shanika de Silva, Christopher Ma, Marie‐Claude Proulx,

Clinical Gastroenterology and Hepatology

2011

180

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas,

The Lancet

2023

126

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

Neil Chanchlani, Simeng Lin, Claire Bewshea,

˜The œLancet. Gastroenterology & hepatology

2024

108

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou,

˜The œLancet. Gastroenterology & hepatology

2022

35

Page 1